Encompass Health Co. (NYSE:EHC) Shares Purchased by Linden Thomas Advisory Services LLC

Linden Thomas Advisory Services LLC raised its position in Encompass Health Co. (NYSE:EHC) by 1.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,473 shares of the company’s stock after purchasing an additional 253 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Encompass Health were worth $1,032,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Treasurer of the State of North Carolina grew its stake in shares of Encompass Health by 0.5% in the third quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock worth $3,246,000 after purchasing an additional 231 shares in the last quarter. Handelsbanken Fonder AB increased its stake in Encompass Health by 1.9% during the 4th quarter. Handelsbanken Fonder AB now owns 15,953 shares of the company’s stock valued at $1,064,000 after buying an additional 300 shares during the period. Personal CFO Solutions LLC increased its stake in Encompass Health by 5.2% during the 3rd quarter. Personal CFO Solutions LLC now owns 6,231 shares of the company’s stock valued at $419,000 after buying an additional 310 shares during the period. EverSource Wealth Advisors LLC lifted its position in Encompass Health by 14.7% in the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company’s stock worth $182,000 after purchasing an additional 347 shares during the period. Finally, Verdence Capital Advisors LLC raised its stake in shares of Encompass Health by 7.1% in the 3rd quarter. Verdence Capital Advisors LLC now owns 5,580 shares of the company’s stock worth $375,000 after buying an additional 370 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Up 0.3 %

Shares of EHC stock opened at $82.72 on Thursday. The firm has a 50-day moving average price of $77.89 and a 200 day moving average price of $70.67. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $83.73. The company has a market capitalization of $8.28 billion, a P/E ratio of 23.84, a P/E/G ratio of 1.53 and a beta of 0.94. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The business had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. Research analysts forecast that Encompass Health Co. will post 3.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.15 per share. The ex-dividend date was Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. Encompass Health’s dividend payout ratio (DPR) is currently 17.29%.

Wall Street Analyst Weigh In

EHC has been the subject of a number of research analyst reports. Barclays upped their price target on shares of Encompass Health from $95.00 to $101.00 and gave the company an “overweight” rating in a report on Thursday, March 28th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a research report on Friday, February 9th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Finally, Mizuho lifted their price target on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Thursday. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Encompass Health currently has an average rating of “Buy” and an average target price of $84.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.